BIOLIFE SOLUTIONS INC (BLFS) Stock Cash Flow
NASDAQ:BLFS - Nasdaq - US09062W2044 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.41M | -20.18M | -66.43M | -139.81M | -8.91M | |||
| Depreciation Amortization | 7.77M | 8.66M | 12.29M | 16.48M | 12.86M | |||
| Income Taxes - Deferred | -63.00K | -64.00K | -62.00K | -5.24M | -20.13M | |||
| Change In Working Capital | -896.00K | 227.00K | 1.47M | -14.91M | -2.26M | |||
| Interest Paid | 1.43M | 1.61M | 1.93M | 590.00K | 450.00K | |||
| Other non cash items | 18.24M | 19.79M | 40.23M | 134.99M | 13.84M | |||
| OPERATING CASH FLOW | 14.63M | 8.43M | -12.50M | -8.49M | -4.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.20M | -5.59M | -11.24M | -13.92M | -14.76M | |||
| Other Investing Activity | 36.55M | 63.90M | 29.07M | -44.20M | 1.56M | |||
| INVESTING CASH FLOW | 31.34M | 58.30M | 17.84M | -58.12M | -13.19M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -8.87M | -6.61M | -498.00K | 17.84M | -2.89M | |||
| Stock Issued/Repurchased | N/A | 202.00K | 10.75M | 320.00K | 1.42M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | -158.00K | -377.00K | 338.00K | -1.84M | -1.30M | |||
| FINANCING CASH FLOW | -8.82M | -6.78M | 10.59M | 16.32M | -2.78M | |||
| Exchange Rate Effect | 65.00K | 0.00 | 35.00K | -110.00K | -20.00K | |||
| CHANGE IN CASH | 37.22M | 59.95M | 15.96M | -50.40M | -20.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 14.63M | 8.43M | -12.50M | -8.49M | -4.59M | |||
| Capital Expenditure | -5.20M | -5.59M | -11.24M | -13.92M | -14.76M | |||
| FREE CASH FLOW | 9.43M | 2.84M | -23.73M | -22.41M | -19.35M | |||
All data in USD